BREAST CANCER METASTATIC
Clinical trials for BREAST CANCER METASTATIC explained in plain language.
Never miss a new study
Get alerted when new BREAST CANCER METASTATIC trials appear
Sign up with your email to follow new studies for BREAST CANCER METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Zapping cancer spots: could radiation buy more time on current meds?
Disease control Not yet recruitingThis study looks at whether adding precise radiation (SABR) to the current hormone therapy and CDK4/6 inhibitor can delay the need to change cancer drugs in people with ER-positive, HER2-negative advanced breast cancer that has started to grow in a few spots. About 74 participant…
Matched conditions: BREAST CANCER METASTATIC
Phase: NA • Sponsor: Peter MacCallum Cancer Centre, Australia • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Plant-Based diet trial aims to boost quality of life in advanced cancer
Disease control Not yet recruitingThis study tests whether a whole food, plant-based diet can improve quality of life and dietary habits in 60 women with metastatic breast or stage IV endometrial cancer. Participants will receive nutrition education and food delivery, and researchers will track diet adherence and…
Matched conditions: BREAST CANCER METASTATIC
Phase: NA • Sponsor: University of Rochester • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New combo aims to outsmart recurrent breast cancer in phase 2 trial
Disease control Not yet recruitingThis study tests whether a combination of fulvestrant and ribociclib works better than standard treatments for people with a certain type of advanced breast cancer (HR+, HER2-) that came back after they finished a previous targeted therapy. About 272 adults will be randomly assig…
Matched conditions: BREAST CANCER METASTATIC
Phase: PHASE2 • Sponsor: Yeon Hee Park • Aim: Disease control
Last updated May 12, 2026 13:39 UTC
-
Promising drug targets Hard-to-Treat breast cancer in Early-Stage trial
Disease control Not yet recruitingThis study tests whether the drug sacituzumab govitecan can slow down advanced triple-negative breast cancer when used as the very first treatment. About 24 adults who have not had prior therapy for their advanced cancer will receive the drug on days 1 and 8 of each 21-day cycle.…
Matched conditions: BREAST CANCER METASTATIC
Phase: PHASE2 • Sponsor: Nathalie Levasseur • Aim: Disease control
Last updated May 12, 2026 13:39 UTC
-
New MRI dye could spot brain tumors sooner in cancer patients
Diagnosis Not yet recruitingThis study tests whether a new MRI contrast agent, gadopiclenol, can detect brain metastases earlier than standard methods in 180 patients with advanced lung cancer, melanoma, or breast cancer. Participants will undergo screening brain MRIs to see if the new dye speeds up diagnos…
Matched conditions: BREAST CANCER METASTATIC
Phase: PHASE2 • Sponsor: University of Zurich • Aim: Diagnosis
Last updated May 16, 2026 23:37 UTC